Abbott Laboratories Sees Institutional Surge and Dividend Hike

Abbott Laboratories (ABT) is witnessing a significant boost in investor confidence following a series of positive institutional and internal developments. Caisse Des Depots ET Consignations substantially increased its stake in the healthcare giant by 61.7% during the third quarter. Adding to the bullish sentiment, an Abbott director recently purchased 10,000 shares, signaling strong internal conviction in the company's trajectory. The company also rewarded shareholders by raising its quarterly dividend to $0.63 per share. Furthermore, management provided optimistic earnings per share (EPS) guidance for the 2026 fiscal year. These factors combined highlight Abbott's robust fundamental health and long-term growth potential in the global healthcare sector.